CONOLIDINE - AN OVERVIEW

These final results, along with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the principle of targeting ACKR3 as a novel approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders.In response to this issue, The brand n